Beximco Pharmaceuticals Limited (BXP.L)
GBp 34.5
(-11.54%)
GBp 34.5
(-11.54%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 19.63 Billion BDT | N/A |
| 2022 | 17.31 Billion BDT | 9.48% |
| 2021 | 15.81 Billion BDT | 13.58% |
| 2020 | 13.92 Billion BDT | 17.01% |
| 2019 | 11.89 Billion BDT | 12.04% |
| 2018 | 10.62 Billion BDT | 28.17% |
| 2017 | 8.28 Billion BDT | 15.33% |
| 2016 | 7.18 Billion BDT | 19.74% |
| 2015 | 6 Billion BDT | 17.56% |
| 2014 | 5.1 Billion BDT | 5.48% |
| 2013 | 4.83 Billion BDT | 10.24% |
| 2012 | 4.38 Billion BDT | 15.92% |
| 2011 | 3.78 Billion BDT | 19.33% |
| 2010 | 3.17 Billion BDT | 37.84% |
| 2009 | 2.3 Billion BDT | 14.69% |
| 2008 | 2 Billion BDT | 23.19% |
| 2007 | 1.62 Billion BDT | -5.87% |
| 2006 | 1.73 Billion BDT | 11.07% |
| 2005 | 1.55 Billion BDT | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q3 | 4.8 Billion BDT | -1.81% |
| 2023 Q1 | 4.88 Billion BDT | 15.3% |
| 2023 Q2 | 4.89 Billion BDT | 0.21% |
| 2022 Q1 | 4.42 Billion BDT | 23.08% |
| 2022 FY | 17.31 Billion BDT | 9.48% |
| 2022 Q4 | 4.23 Billion BDT | 0.47% |
| 2022 Q3 | 4.21 Billion BDT | -5.11% |
| 2022 Q2 | 4.44 Billion BDT | 0.37% |
| 2021 Q4 | 3.59 Billion BDT | -11.23% |
| 2021 Q3 | 4.04 Billion BDT | -1.07% |
| 2021 Q2 | 4.09 Billion BDT | 0.42% |
| 2021 FY | 15.81 Billion BDT | 13.58% |
| 2021 Q1 | 4.07 Billion BDT | 11.71% |
| 2020 Q2 | 3.54 Billion BDT | 7.68% |
| 2020 Q3 | 3.44 Billion BDT | -2.8% |
| 2020 Q4 | 3.64 Billion BDT | 5.99% |
| 2020 Q1 | 3.28 Billion BDT | 9.79% |
| 2020 FY | 13.92 Billion BDT | 17.01% |
| 2019 FY | 11.89 Billion BDT | 12.04% |
| 2019 Q4 | 2.99 Billion BDT | -3.19% |
| 2019 Q3 | 3.09 Billion BDT | 7.98% |
| 2019 Q2 | 2.86 Billion BDT | -2.56% |
| 2019 Q1 | 2.94 Billion BDT | 7.99% |
| 2018 Q4 | 2.72 Billion BDT | -0.08% |
| 2018 FY | 10.62 Billion BDT | 28.17% |
| 2018 Q2 | 2.64 Billion BDT | 4.35% |
| 2018 Q1 | 2.52 Billion BDT | 10.04% |
| 2018 Q3 | 2.72 Billion BDT | 3.27% |
| 2017 Q3 | 1.99 Billion BDT | -0.73% |
| 2017 FY | 8.28 Billion BDT | 15.33% |
| 2017 Q4 | 2.29 Billion BDT | 15.02% |
| 2017 Q2 | 2.01 Billion BDT | 2.0% |
| 2017 Q1 | 1.97 Billion BDT | 6.98% |
| 2016 Q2 | 1.81 Billion BDT | 5.08% |
| 2016 Q1 | 1.73 Billion BDT | 23.3% |
| 2016 Q4 | 1.84 Billion BDT | 3.18% |
| 2016 FY | 7.18 Billion BDT | 19.74% |
| 2016 Q3 | 1.78 Billion BDT | -1.7% |
| 2015 Q4 | 1.4 Billion BDT | -8.42% |
| 2015 Q1 | 1.51 Billion BDT | 1.94% |
| 2015 FY | 6 Billion BDT | 17.56% |
| 2015 Q2 | 1.66 Billion BDT | 10.01% |
| 2015 Q3 | 1.53 Billion BDT | -7.8% |
| 2014 Q1 | 1.34 Billion BDT | 5.15% |
| 2014 Q4 | 1.48 Billion BDT | 10.49% |
| 2014 FY | 5.1 Billion BDT | 5.48% |
| 2014 Q2 | 1.34 Billion BDT | -0.33% |
| 2014 Q3 | 1.34 Billion BDT | 0.07% |
| 2013 Q2 | 1.37 Billion BDT | 12.34% |
| 2013 FY | 4.83 Billion BDT | 10.24% |
| 2013 Q4 | 1.27 Billion BDT | 12.56% |
| 2013 Q1 | 1.22 Billion BDT | -1.12% |
| 2013 Q3 | 1.13 Billion BDT | -17.37% |
| 2012 Q4 | 1.23 Billion BDT | 24.07% |
| 2012 Q2 | 1.2 Billion BDT | -0.75% |
| 2012 Q1 | 1.2 Billion BDT | 24.4% |
| 2012 FY | 4.38 Billion BDT | 15.92% |
| 2012 Q3 | 998.63 Million BDT | -16.83% |
| 2011 Q3 | 1 Billion BDT | 0.85% |
| 2011 Q4 | 972.55 Million BDT | -3.35% |
| 2011 Q2 | 997.78 Million BDT | -6.51% |
| 2011 FY | 3.78 Billion BDT | 19.33% |
| 2011 Q1 | 1.06 Billion BDT | 11.34% |
| 2010 Q3 | 762.77 Million BDT | 0.8% |
| 2010 Q1 | 932.02 Million BDT | 9.36% |
| 2010 FY | 3.17 Billion BDT | 37.84% |
| 2010 Q4 | 958.6 Million BDT | 25.67% |
| 2010 Q2 | 756.75 Million BDT | -18.81% |
| 2009 Q4 | 852.26 Million BDT | 34.83% |
| 2009 Q3 | 632.12 Million BDT | -4.55% |
| 2009 FY | 2.3 Billion BDT | 14.69% |
| 2009 Q1 | 553.39 Million BDT | -2.25% |
| 2009 Q2 | 662.23 Million BDT | 19.67% |
| 2008 Q4 | 566.11 Million BDT | 8.8% |
| 2008 FY | 2 Billion BDT | 23.19% |
| 2008 Q3 | 520.31 Million BDT | 0.0% |
| 2007 FY | 1.62 Billion BDT | -5.87% |
| 2006 FY | 1.73 Billion BDT | 11.07% |
| 2005 FY | 1.55 Billion BDT | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|